# Tranexamic Acid (TXA) in Hip Arthroscopy

> **NCT05710146** · PHASE3 · WITHDRAWN · sponsor: **Northwestern University**

## Conditions studied

- Hip Pain Chronic
- Hip Impingement Syndrome
- Hip Injuries
- Blood Loss
- Femoro Acetabular Impingement

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05710146
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12
- **Primary completion:** 2024-03
- **Final completion:** 2024-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was never started. Did not receive funding.
- **Last updated:** 2023-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05710146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05710146, "Tranexamic Acid (TXA) in Hip Arthroscopy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05710146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*